NEW YORK, Jan. 9, 2015 /PRNewswire/ -- SurePure, Inc. (OTCBB: SURP) a global leader in liquid photopurification, is pleased to announce that its patented photopurification technology is seen as instrumental in the success of the clinical trials being conducted by Tamarack Biotics.
Tamarack Biotics is developing and plans to clinically test milk that has been pasteurized with SurePure's equipment. SurePure's equipment has demonstrated the ability to kill pathogens at relatively low energies, allowing valuable compounds to remain undiminished in quantity and quality.
Bob Comstock, CEO for Tamarack Biotics stated, "We believe SurePure's technology and products are critical to the success of our project."
Guy Kebble, CEO for SurePure stated, "This application and the clinical trial reflect the value of the SurePure technology in achieving microbial cleanliness while retaining the inherent qualities of the product. We are pleased to be partnering with Tamarack in this regard."
SurePure is a global leader in liquid photopurification, the green alternative to pasteurization and chemicals. Using its patented 'Turbulator' technology, SurePure systems use UV-C light to purify microbiologically sensitive liquids such as wine, fruit juice and milk. Although designed to deliver food-grade solutions, it can also be harnessed to improve processing liquids such as water, brines and sugar syrup solutions, even animal blood plasma. SurePure's technology offers greater microbiological efficacy than conventional UV systems and is effective for both clear and turbid liquids, a world first. SurePure offers a greener alternative to comparable heat or chemical-based processes and significant process and energy savings. It also provides opportunities for the development of innovative and differentiated products with desired consumer benefits, guaranteed food safety and sound commercial benefits. Go to www.surepureinc.com for more information.
SOURCE SurePure, Inc.